Tag Archives: PitchBook

← Older posts

Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More

If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook. This week […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Europe blog main, Europe top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Philadelphia Blog Main, Philadelphia Top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More

Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

COVID-19’s spread has clamped down on a lot of economic activity, including the work of developing and testing new medicines. But the FDA isn’t showing signs of slowing down, at least when it comes to drugs filed for accelerated approval. The regulator signed off on three such drugs in the past week. These approvals are […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Europe blog main, Europe top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More

Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle

Even as the novel coronavirus has derailed daily life and business operations, the life sciences sector continues to see companies make public debuts and ink both financing and partnership deals. In venture capital, US deal activity in the first quarter tallied 2,300 financings totaling $34.2 billion, according to the latest report by the National Venture […]

Posted in National, National blog main, National top stories | Tagged , , , , , , , , , , , , , | Comments Off on Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle

Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod

A Cushing’s disease drug whose rights Novartis sold to Italy-based Recordati last year now has FDA approval. Cushing’s disease is a rare disorder in which the adrenal glands make too much of a hormone called cortisol. The Novartis (NYSE: NVS) drug, osilodrostat (Isturisa), is intended to block an enzyme key to cortisol production. The FDA […]

Posted in Boston blog main, Boston top stories, Europe, Europe blog main, Europe top stories, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , | Comments Off on Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod

Pharma, Biotech VC Investments Continue Shift to Early Stage Deals

The number of investments that venture capitalists will make this year in pharmaceutical and biotech companies is on pace to match last year’s record—and that money continues to shift into earlier-stage deals. Venture firms invested in 609 drug development deals as of Sept. 30, 2019, compared with 808 deals for all last year, according to […]

Posted in National, National blog main, National top stories | Tagged , , , , , | Comments Off on Pharma, Biotech VC Investments Continue Shift to Early Stage Deals

High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers

Ginkgo Bioworks, a synthetic biology specialist that has become worth billions, has raised another $290 million to expand the breadth of a technology that tinkers with a cell’s genetic code and reprograms it—like programming a computer. Boston-based Ginkgo uses a combination of software and robotic systems to design organisms. It started out making microbes engineered […]

Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers

Artemis Fund, TechStars Impact, Robin Autopilot, & More TX Tech

Let’s catch up with the latest innovation news in Texas. —Mark Cuban and Serena Williams are among investors to fund maternal health startup Mahmee. The Los Angeles-based startup announced Monday it has raised $3 million from the Dallas Mavericks owner and the tennis star (through her firm Serena Ventures) in a round led by ArlanWasHere […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Artemis Fund, TechStars Impact, Robin Autopilot, & More TX Tech

Record Exit Value for VC-Backed Startups Could Fuel Investment

More than a third of the companies that went public in the first half of this year were backed by venture capital. That, plus robust merger and acquisition activity, set a record for venture-backed exit value—$165.2 billion in money returned to investors—that’s already topped all other full-year totals, according to the latest VentureMonitor, the quarterly […]

Posted in Boston blog main, Detroit blog main, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, San Francisco top stories, Seattle blog main, Texas blog main, Wisconsin blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Record Exit Value for VC-Backed Startups Could Fuel Investment

Grocer H-E-B Explores Autonomous Delivery With SF-Area Startup Udelv

San Antonio — Pretty soon, the milkman may be making a comeback—at least, a robotic version. San Antonio-based grocery chain H-E-B is beginning a pilot program later this year to test out using an autonomous vehicle for grocery delivery. H-E-B plans to test one self-driving vehicle in a single San Antonio neighborhood, Olmos Park. The company […]

Posted in National blog main, San Francisco blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Grocer H-E-B Explores Autonomous Delivery With SF-Area Startup Udelv

VidMob Adds $25M Led by Austin-Based BuildGroup for Adtech Software

You’ve probably seen a VidMob advertisement, or at least an ad the company had some influence on, and not known it. The New York-based startup has helped make or optimize digital ads created for smartphones for brands ranging from Netflix (NASDAQ: NFLX) to Arby’s (“We Have the Meats!”). The company has software that lets the […]

Posted in National blog main, New York, New York blog main, New York top stories, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on VidMob Adds $25M Led by Austin-Based BuildGroup for Adtech Software← Older posts